We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Urine Particle Analyzer Compared with Standard Methods

By LabMedica International staff writers
Posted on 20 Nov 2017
Urinary tract infections (UTIs) are characterized by the presence of microbial pathogens within the urinary tract, and they represent one of the most common infections identified in both hospitalized and clinic patients. More...
Most UTIs are easily treated without difficulty.

In certain patient populations, such as children, pregnant women, and the elderly, significant complications may arise. The symptoms observed with UTIs are diverse and can range from mild irritation with voiding to bacteremia or even sepsis. When sepsis is present, it can lead to death if it is not diagnosed and treated early.

Medical scientists working at Prescient Medicine (Hummelstown, PA, USA) and their colleagues compared data from urine samples collected in sterile containers for bacterial culture and microscopic analysis during a 3-month period in a laboratory at a 572-bed, acute-care hospital. Upon receipt, one sample was used to inoculate a 5% sheep blood agar and a MacConkey agar plate with a 0.001-mL calibrated loop.

The second sample was analyzed for bacteria and leukocytes with the Sysmex UF-1000i urine analyzer (Sysmex Corporation, Kobe, Japan) which is a fully automated, fluorescent flow cytometer that categorizes red blood cells, white blood cells, epithelial cells, small round cells, sperm cells, crystals, and pathologic and hyaline casts, yeast, and bacteria. The second sample was also analyzed by urinalysis-associated microscopy for the presence of epithelial cells, leukocytes, yeast, and bacteria.

Urine cultures showed no growth in 2,034 samples (50%) and growth of less than 104 colony-forming units (CFUs)/mL in 1,812 samples (45%). Of the 4.033 results, 754 samples (19%) showed bacterial growth of 105 CFUs/mL or more, and 190 samples (5%) were considered contaminated specimens because they contained multiple species. However, if the growth of bacteria exceeded the definition of a negative result, they were considered to be positive, even though the likelihood of a UTI was low in those patients. Of the culture-positive samples, the most commonly identified microorganisms were Escherichia coli and Klebsiella spp, which is consistent with known epidemiologic data.

Of the 4,033 unique urine samples obtained from adult patients, 2,736 (67.8%) specimens had positive white blood cell counts and bacteria and 1,215 (30.1%) specimens had negative white blood cell counts and bacteria as reported by the UF-1000i. The negative predictive value for any positive culture in the adult population included in the study was 95.5%, and the negative predictive value for positive cultures containing growth of 100,000 or more CFUs was 99.3% using the Sysmex UF-1000i. There were 373 unique urine specimens collected in pediatric patients and using the UF-1000i method, 269 specimens (72%) had positive white blood cell counts and bacteria, and 104 (27.9%) tested negative for an elevation in white blood cell counts and bacteria.

The authors concluded that the Sysmex UF-1000i showed 98% sensitivity and 93.7% specificity with a 95.5% negative predictive value. Thus, a negative screen with the UF-1000i using defined thresholds for white blood cell counts and bacteria was likely to be a true negative, decreasing the need for presumptive antibiotics. The study was published in the November 2017 issue of the journal Archives of Pathology & Laboratory Medicine.


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HbA1c Test
HbA1c Rapid Test
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: A blood test for many cancers could potentially thwart progression to late stage in up to half of cases (Photo courtesy of Shutterstock)

Single Blood Test Could Detect Different Types of Cancer at Early Stages

Currently, reliable screening for only a few types of cancer is available, such as those affecting the breast, bowel, cervix (neck of the womb), and lung for individuals at high risk. While these screenings... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.